Literature DB >> 8864200

Porcine adenoviruses types 1, 2 and 3 have short and simple early E-3 regions.

P S Reddy1, N Idamakanti, J B Derbyshire, E Nagy.   

Abstract

The nucleotide sequence of the E-3 region genes, the hexon associated protein pVIII genes, and part of the fiber genes coding for the N-terminal tail regions, of porcine adenovirus (PAV) types 1 and 2 were determined. The sizes of the E-3 regions were found to be 1162 and 1222 bp, respectively. The five open reading frames (ORF) encoded within the sequenced regions of PAV types 1 and 2 shared a high degree of homology with the published sequences of the corresponding ORFs of PAV-3. The E-3 regions of PAV types 1, 2 and 3 were further characterized by Northern blot analysis and 5' and 3' end mapping of the transcripts by S1 nuclease analysis. The results of these experiments indicated that the E-3 regions in these three viruses are shorter and simpler in organization than the E-3 regions of human adenoviruses. A potential promoter for the E-3 regions of these PAVs was identified.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864200     DOI: 10.1016/0168-1702(96)01336-6

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

1.  Characterization of early region 4 of porcine adenovirus serotype 5.

Authors:  T Tuboly; M Nagy; E Nagy
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Porcine Adenovirus Type 3 E3 Encodes a Structural Protein Essential for Capsid Stability and Production of Infectious Progeny Virions.

Authors:  Abdelrahman Said; Tekeleselassie A Woldemariam; Suresh K Tikoo
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

3.  Characterization of the early region 4 of porcine adenovirus type 3.

Authors:  P S Reddy; N Idamakanti; J B Derbyshire; E Nagy
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

Review 4.  Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics.

Authors:  Jef M Hammond; Michael A Johnson
Journal:  Vet J       Date:  2005-01       Impact factor: 2.688

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.